Superficial gyrate erythema as a cutaneous reaction to alendronate for osteoporosis.
Alendronate is a bisphosphonate compound used to treat diseases of pathologic bone resorption. Cutaneous reactions to this medication are rare. We report the case of a superficial gyrate erythema that occurred as a reaction to weekly alendronate therapy used in the treatment of postmenopausal osteoporosis.
High
Whitney A
WA
Department of Dermatology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-9190, USA.
Cohen
Jack B
JB
Wetherington
Wesley
W
Cockerell
Clay J
CJ
D000368:Aged; D019386:Alendronate / Q000009:adverse effects* / Q000627:therapeutic use; D004890:Erythema / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy
D019386:Alendronate